| scholarly article | Q13442814 |
| P2093 | author name string | Akio Ohta | |
| Michail Sitkovsky | |||
| P2860 | cites work | Repression of Cyclic Adenosine Monophosphate Upregulation Disarms and Expands Human Regulatory T Cells | Q60315852 |
| Generation of anti-inflammatory adenosine byleukocytes is regulated by TGF-β | Q61651632 | ||
| The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites | Q70988415 | ||
| Adenosine in bronchoalveolar lavage fluid in asthma | Q72796936 | ||
| High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock | Q73014129 | ||
| Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function | Q73112984 | ||
| Renal interstitial concentration of adenosine during endotoxin shock | Q73295599 | ||
| The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine | Q73470605 | ||
| Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat ad | Q73574475 | ||
| Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury | Q80428036 | ||
| Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling | Q80491718 | ||
| Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia | Q81250637 | ||
| Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1 | Q24336199 | ||
| Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 | ||
| Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury | Q24796780 | ||
| Cyclic AMP underpins suppression by regulatory T cells | Q26824574 | ||
| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
| Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage | Q28214799 | ||
| Exploiting tumour hypoxia in cancer treatment | Q28264146 | ||
| Hypoxia in cancer: significance and impact on clinical outcome | Q28298305 | ||
| Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice | Q28298659 | ||
| Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion | Q28507222 | ||
| Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice | Q28512453 | ||
| Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport | Q28571989 | ||
| Adenosine receptors in regulation of dendritic cell differentiation and function | Q28586835 | ||
| Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury | Q28593969 | ||
| Adenosine receptors as drug targets--what are the challenges? | Q29346491 | ||
| Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
| Immunosuppressive strategies that are mediated by tumor cells | Q29636247 | ||
| Adenosine A2B receptor blockade slows growth of bladder and breast tumors | Q30416420 | ||
| Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection | Q30417431 | ||
| Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology | Q30433245 | ||
| A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence | Q30433250 | ||
| A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
| Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 | ||
| Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition | Q30443210 | ||
| CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression | Q33533705 | ||
| Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis | Q33667612 | ||
| Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells | Q33748026 | ||
| Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal. | Q33940441 | ||
| CD39/adenosine pathway is involved in AIDS progression | Q33959186 | ||
| Inflammatory hypoxia: role of hypoxia-inducible factor. | Q33984426 | ||
| Advances in graft-versus-host disease biology and therapy | Q34031916 | ||
| Purinergic signaling during inflammation | Q34034751 | ||
| Cellular constituents of immune escape within the tumor microenvironment | Q38020632 | ||
| Development and maintenance of regulatory T cells | Q38092234 | ||
| A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application | Q38163290 | ||
| Regulatory T cells as immunotherapy | Q38191610 | ||
| A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments | Q39785317 | ||
| Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides | Q39797150 | ||
| Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines | Q40119910 | ||
| Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes. | Q40491983 | ||
| IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation | Q40597263 | ||
| Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor | Q41545207 | ||
| Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats | Q42509429 | ||
| Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease | Q43075747 | ||
| Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction | Q43090511 | ||
| Methotrexate--how does it really work? | Q43144564 | ||
| Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling | Q43279099 | ||
| Regulatory T cells and transplantation tolerance. | Q43563597 | ||
| CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness | Q43943686 | ||
| Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor | Q43946696 | ||
| Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. | Q44525306 | ||
| Blunted increase in plasma adenosine levels following dipyridamole stress in dilated cardiomyopathy patients | Q44671126 | ||
| Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice | Q44927020 | ||
| Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha | Q44948359 | ||
| T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response | Q45292627 | ||
| Interferon-α suppresses cAMP to disarm human regulatory T cells. | Q45955170 | ||
| Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. | Q46013858 | ||
| CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. | Q46019176 | ||
| Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection | Q46054691 | ||
| Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor | Q46605600 | ||
| Control of IFN-alphaA by CD73: implications for mucosal inflammation | Q46717032 | ||
| HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak | Q46726814 | ||
| Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide. | Q54722219 | ||
| Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner | Q56897543 | ||
| Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells | Q34107172 | ||
| Regulatory T cells and Foxp3 | Q34177949 | ||
| Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation | Q34184568 | ||
| Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation. | Q34462015 | ||
| T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine | Q34578972 | ||
| Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression | Q34579516 | ||
| CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. | Q34599954 | ||
| Graft-versus-host disease is enhanced by selective CD73 blockade in mice | Q34631798 | ||
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
| Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis | Q34776189 | ||
| Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia | Q34797847 | ||
| A2A adenosine receptor protects tumors from antitumor T cells. | Q35016529 | ||
| HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells | Q35102340 | ||
| Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells | Q35566772 | ||
| Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. | Q35698535 | ||
| Distinctive immunoregulatory effects of adenosine on T cells of older humans | Q35787747 | ||
| Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease | Q35995245 | ||
| The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. | Q36075960 | ||
| Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID | Q36185196 | ||
| Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa | Q36339991 | ||
| Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation | Q36404222 | ||
| Host A(2B) adenosine receptors promote carcinoma growth | Q36840284 | ||
| CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. | Q36860320 | ||
| Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease | Q36907484 | ||
| Creating immune privilege: active local suppression that benefits friends, but protects foes. | Q37026641 | ||
| Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. | Q37256978 | ||
| Role for the cAMP-protein kinase A signaling pathway in suppression of antitumor immune responses by regulatory T cells | Q37357253 | ||
| Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73). | Q37363358 | ||
| A(2B) adenosine receptors in immunity and inflammation. | Q37373680 | ||
| Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer | Q37390515 | ||
| CD73: A Novel Target for Cancer Immunotherapy | Q37777541 | ||
| Interplay of hypoxia and A2B adenosine receptors in tissue protection | Q37876539 | ||
| Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity | Q37876541 | ||
| CD73: a potent suppressor of antitumor immune responses | Q38001161 | ||
| P304 | page(s) | 304 | |
| P577 | publication date | 2014-07-10 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Extracellular adenosine-mediated modulation of regulatory T cells | |
| P478 | volume | 5 |
| Q36176421 | 1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cells |
| Q26749571 | A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment |
| Q88083382 | Activation of adenosine A2A or A2B receptors causes hypothermia in mice |
| Q28074665 | Adenosine A2B Receptor: From Cell Biology to Human Diseases |
| Q38767892 | Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities |
| Q47171708 | Adenosine in the Thymus |
| Q36976612 | Adenosine influences myeloid cells to inhibit aeroallergen sensitization |
| Q38936385 | Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. |
| Q59354766 | Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection |
| Q56962743 | Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment |
| Q90704170 | Adenosinergic signaling as a target for natural killer cell immunotherapy |
| Q60960593 | CD39 regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function |
| Q55282181 | CD73 expression and clinical significance in human metastatic melanoma. |
| Q92932103 | CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint |
| Q38766028 | Cell-Based Therapies with T Regulatory Cells |
| Q92185716 | Cigarette smoke-induced reduction of C1q promotes emphysema |
| Q64095697 | Circulating CD56 NK cells inversely correlate with survival of melanoma patients |
| Q28072162 | Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation |
| Q37550716 | Divide, Conquer, and Sense: CD8+CD28- T Cells in Perspective |
| Q50224587 | Ectonucleotidase inhibitors: a patent review (2011-2016). |
| Q36853115 | Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals |
| Q90305079 | Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation |
| Q36009621 | FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas |
| Q28080809 | Graft versus host disease: New insights into A2A receptor agonist therapy |
| Q33770125 | Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia |
| Q28069922 | Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs) |
| Q37117183 | High homocysteine levels prevent via H2 S the CoCl2 -induced alteration of lymphocyte viability |
| Q48337262 | Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells |
| Q99584371 | Human regulatory T cells (Treg) and their response to cancer |
| Q92361171 | Hypoxia Compromises Anti-Cancer Immune Responses |
| Q51554659 | Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression. |
| Q46835597 | Hypoxic culture conditions enhance the generation of regulatory T cells |
| Q56890107 | Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options |
| Q57162899 | Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition |
| Q26772723 | Inducing and Administering Tregs to Treat Human Disease |
| Q36430733 | Loss of CD73-mediated actin polymerization promotes endometrial tumor progression |
| Q37439267 | MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response |
| Q90043581 | Melanoma Metabolism: Cell Survival and Resistance to Therapy |
| Q47112411 | Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo |
| Q97424076 | Metabolism of immune cells in cancer |
| Q52883482 | Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1). |
| Q64123495 | Microenvironment tailors nTreg structure and function |
| Q37266957 | Modulation of Phenotype and Function of Human CD4+CD25+ T Regulatory Lymphocytes Mediated by cAMP-Elevating Agents |
| Q38482206 | New approaches for the immunotherapy of acute myeloid leukemia |
| Q60305312 | Non-specific Effects of Live Attenuated Pertussis Vaccine Against Heterologous Infectious and Inflammatory Diseases |
| Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
| Q47310583 | On the G protein-coupling selectivity of the native A2B adenosine receptor |
| Q57464717 | Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73CD45RACCR7CD8 T and CD73CD45RACCR7CD8 T Cells Are Associated with Asymptomatic Ocular Herpes |
| Q39281335 | Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). |
| Q38765118 | Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging |
| Q99562886 | Potential of Extracellular Vesicle-Associated TSG-6 from Adipose Mesenchymal Stromal Cells in Traumatic Brain Injury |
| Q92704649 | Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation |
| Q38753350 | Purinergic regulation of the immune system |
| Q60915986 | Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways |
| Q90220063 | Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy |
| Q26746113 | Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation |
| Q26745537 | Regulatory T-Cell-Mediated Suppression of Conventional T-Cells and Dendritic Cells by Different cAMP Intracellular Pathways |
| Q38809776 | Reversing T-cell Dysfunction and Exhaustion in Cancer |
| Q38843185 | Safety issues of compounds acting on adenosinergic signalling |
| Q35897785 | Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP. |
| Q38644779 | Stabilizing human regulatory T cells for tolerance inducing immunotherapy |
| Q47135720 | Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma |
| Q58796913 | Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis |
| Q92405303 | T Cell Dysfunction in Cancer Immunity and Immunotherapy |
| Q40066649 | TCR-pMHC encounter differentially regulates transcriptomes of(-) tissue-resident CD8 T cells. |
| Q46140918 | Targeting immunosuppressive adenosine in cancer |
| Q39228029 | Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life |
| Q38686607 | The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges. |
| Q51264924 | The GS Protein-coupled A2a Adenosine Receptor Controls T Cell Help in the Germinal Center. |
| Q48191363 | The Hypoxia-Adenosine Link during Intestinal Inflammation. |
| Q90394392 | The SNP rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity |
| Q55019858 | The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment. |
| Q104068523 | Treg cell therapy: how cell heterogeneity can make the difference |
| Q26861133 | αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy |
Search more.